Found: 13
Select item for more details and to access through your institution.
Serum Soluble TACI, a BLyS Receptor, Is a Powerful Prognostic Marker of Outcome in Chronic Lymphocytic Leukemia.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Clonotypic Analysis of Immunoglobulin Heavy Chain Sequences in Patients with Waldenström's Macroglobulinemia: Correlation with MYD88 L265P Somatic Mutation Status, Clinical Features, and Outcome.
- Published in:
- BioMed Research International, 2014, v. 2014, p. 1, doi. 10.1155/2014/809103
- By:
- Publication type:
- Article
Serum Soluble TACI, a BLyS Receptor, Is a Powerful Prognostic Marker of Outcome in Chronic Lymphocytic Leukemia.
- Published in:
- BioMed Research International, 2014, v. 2014, p. 1, doi. 10.1155/2014/159632
- By:
- Publication type:
- Article
Prognostic Significance of Serum Free Light Chains in Chronic Lymphocytic Leukemia.
- Published in:
- Advances in Hematology, 2013, p. 1, doi. 10.1155/2013/359071
- By:
- Publication type:
- Article
Validation of Frailty Assessment in Multiple Myeloma (MM) Patients.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e137, doi. 10.1016/j.clml.2017.03.247
- By:
- Publication type:
- Article
Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma.
- Published in:
- British Journal of Haematology, 2007, v. 137, n. 3, p. 240, doi. 10.1111/j.1365-2141.2007.06561.x
- By:
- Publication type:
- Article
Novel M-component based biomarkers in Waldenström's macroglobulinemia.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
CD138 expression helps distinguishing Waldenström's macroglobulinemia (WM) from splenic marginal zone lymphoma (SMZL)
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Novel M-Component Based Biomarkers in Waldenström's Macroglobulinemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2011, v. 11, n. 1, p. 164, doi. 10.3816/CLML.2011.n.039
- By:
- Publication type:
- Article
CD138 Expression Helps Distinguishing Waldenström's Macroglobulinemia (WM) From Splenic Marginal Zone Lymphoma (SMZL).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2011, v. 11, n. 1, p. 99, doi. 10.3816/CLML.2011.n.019
- By:
- Publication type:
- Article
Re-evaluation of prognostic markers including staging, serum free light chains or their ratio and serum lactate dehydrogenase in multiple myeloma patients receiving novel agents.
- Published in:
- Hematological Oncology, 2013, v. 31, n. 2, p. 356, doi. 10.1002/hon.2026
- By:
- Publication type:
- Article
Could Immunophenotype Guide Molecular Analysis in Patients With Myeloid Malignancies?
- Published in:
- Hospital Chronicles, 2019, v. 14, n. 1, p. 13
- By:
- Publication type:
- Article
Genetic and molecular mechanisms in multiple myeloma: a route to better understand disease pathogenesis and heterogeneity.
- Published in:
- Application of Clinical Genetics, 2010, v. 3, p. 41
- By:
- Publication type:
- Article